Effect of probiotic lactobacillus (Lacidofil® Cap) for the prevention of antibiotic-associated diarrhea: A prospective, randomized, double-blind, multicenter study

Journal of Korean Medical Science

Volumn 25, Issue 12, 2010, Pages 1784-1791

  Song, Hyun Joo ^a   Kim, Jin Yong ^b   Jung, Sung Ae ^a   Kim, Seong Eun ^a   Park, Hye Sook ^a   Jeong, Yoolwon ^a   Hong, Sung Pil ^c   Cheon, Jae Hee ^c   Kim, Won Ho ^c   Kim, Hyo Jong ^d   Ye, Byong Duk ^e   Yang, Suk Kyun ^e   Kim, Sang Woo ^f   Shin, Sung Jae ^g   Kim, Hyun Soo ^h   Sung, Jae Kyu ⁱ   Kim, Eun Young ^j  

^a Ewha Womans University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f The Catholic University of Korea College of Medicine   (South Korea)

^g Ajou University School of Medicine   (South Korea)

^h Yonsei University Wonju College of Medicine   (South Korea)

ⁱ Chungnam National University College of Medicine   (South Korea)

^j Catholic University of Daegu   (South Korea)

more..

Author keywords

Antibiotic associated diarrhea; Lactobacillus; Probiotics

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LACTOBACILLUS; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RISK; RISK FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS; MALE; MIDDLE AGED; ODDS RATIO; PROBIOTICS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 78649931880     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.12.1784     Document Type: Article

References (30)

1. McFarland LV. Epidemiology, risk factors and treatments for antibioticassociated diarrhea. Dig Dis 1998; 16: 292-307.
2. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-9.
3. Ackermann G, Thomalla S, Ackermann F, Schaumann R, Rodloff AC, Ruf BR. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea. J Med Microbiol 2005; 54: 149-53.
4. McFarland LV. Normal flora: diversity and functions. Microb Ecol Health Dis 2000; 12: 193-207.
5. McFarland LV. A review of the evidence of health claims for biotherapeutic agents. Microb Ecol Health Dis 2000; 12: 65-76.
6. Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, LaMont JT, Kelly CP. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 2001; 69: 2762-5.
7. Elmer GW. Probiotics: "Living drugs." Am J Health Syst Pharm 2001; 58: 1101-9.
8. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease activity. CMAJ 2004; 171: 466-72.
9. Katikireddi V. UK launches inquired into Clostridium difficile outbreak. CMAJ 2005; 173: 138.
10. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-22.
11. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-9.
12. Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64.
13. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564-8.
14. Szajewska H, Kotowska M, Mrukowicz JZ, Armańska M, Mikołajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138: 361-5.
15. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76: 883-9.
16. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, Santarelli L, Cammarota G, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1-7.
17. Beausoleil M, Fortier N, Guénette S, L'ecuyer A, Savoie M, Franco M, Lachaine J, Weiss K. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21: 732-6.
18. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335: 80.
19. Kale-Pradhan PB, Jassal HK, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy 2010; 30: 119-26.
20. Szymański H, Armańska M, Kowalska-Duplaga K, Szajewska H. Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion 2008; 78: 13-7.
21. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-3.
22. Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol 1997; 24: 361-4.
23. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37: 121-8.
24. Ling WH, Korpela R, Mykkänen H, Salminen S, Hänninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994; 124: 18-23.
25. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective-study. Gastroenterology 1989; 96: 981-8.
26. Coconnier MH, Liévin V, Bernet-Camard MF, Hudault S, Servin AL. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997; 41: 1046-52.
27. Ruszczyński M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 2008; 28: 154-61.
28. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24: 278-80.
29. Young RJ, Vanderhoof JA. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004; 39: 436-7.
30. Jirapinyo P, Densupsoontorn N, Thamonsiri N, Wongarn R. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002; 85 Suppl 2: S739-42.